UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 9.

Lodwick, R K; Sabin, C A; Porter, K; Ledergerber, B; van Sighem, A; Cozzi-Lepri, A; Khaykin, P; Mocroft, A; Jacobson, L; De Wit, S; Obel, N; Castagna, A; Wasmuth, J C; Gill, J; Klein, M B; Gange, S; Riera, M; Mussini, C; Gutiérrez, F; Touloumi, G; Carrieri, P; Guest, J L; Brockmeyer, N H; Phillips, A N (2010). Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet, 376(9738):340-345.

Smith, C J; Sabin, C A; Lundgren, J D; Thiebaut, R; Weber, R; Law, M; D'Arminio Monforte, A; Kirk, O; Friis-Moller, N; Phillips, A; Reiss, P; El Sadr, W; Pradier, C; Worm, S W (2010). Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS, 24(10):1537-1548.

Friis-Møller, N; Thiebaut, R; Reiss, P; Weber, R; Monforte, A D; De Wit, S; El-Sadr, W; Fontas, E; Worm, S W; Kirk, O; Phillips, A; Sabin, C A; Lundgren, J D; Law, M G (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. European Journal of Cardiovascular Prevention and Rehabilitation, 17(5):491-501.

Worm, S W; De Wit, S; Weber, R; Sabin, C A; Reiss, P; El-Sadr, W; Monforte, A D; Kirk, O; Fontas, E; Dabis, F; Law, M G; Lundgren, J D; Friis-Møller, N (2009). Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation, 119(6):805-811.

D'Arminio Monforte, A; Abramson, D; Pradier, C; Weber, R; Reiss, P; Bonnet, F; Kirk, O; Law, M; De Wit, S; Friis-Møller, N; Phillips, A N; Sabin, C A; Lundgren, J D (2008). HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 22(16):2143-2153.

Lundgren, J D; Neuhaus, J; Babiker, A; Cooper, D; Duprez, D; El-Sadr, W; Emery, S; Gordin, F; Kowalska, J; Phillips, A; Prineas, R J; Sabin, C A; Tracy, R; Weber, R; Grund, B; Neaton, J D (2008). Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS, 22(14):F17-F24.

Sabin, C A; d'Arminio Monforte, A; Friis-Moller, N; Weber, R; El-Sadr, W M; Reiss, P; Kirk, O; Mercie, P; Law, M G; De Wit, S; Pradier, C; Phillips, A N; Lundgren, J D (2008). Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clinical Infectious Diseases, 46(7):1101-1110.

De Wit, S; Sabin, C A; Weber, R; Worm, S W; Reiss, P; Cazanave, C; El-Sadr, W; D'Arminio Monforte, A; Fontas, E; Law, M G; Friis-Møller, N; Phillips, A (2008). Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care, 31(6):1224-1229.

Sabin, C A; Worm, S W; Weber, R; Reiss, P; El-Sadr, W; Dabis, F; De Wit, S; Law, M; D'Arminio Monforte, A; Friis-Møller, N; Kirk, O; Pradier, C; Weller, I; Phillips, A N; Lundgren, J D; D:A:D Study Group (2008). Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet, 371(9622):1417-1426.

This list was generated on Sat Jul 22 13:18:41 2017 CEST.